https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-03-01 / J Clin Oncol 37, 2019 (suppl 8; abstr TPS10)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-03-01 / J Clin Oncol 37, 2019 (suppl 8; abstr TPS10)2019-03-01 00:00:002020-05-06 15:08:24Randomized phase II trial of patient-specific dendritic cell vaccines loaded with autologous tumor antigens versus autologous monocytes in patients with primary advanced ovarian cancer.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-02-27 / Clin Colorectal Cancer 2019 Jun;18(2):81-90
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-02-27 / Clin Colorectal Cancer 2019 Jun;18(2):81-902019-02-27 00:00:002019-02-27 00:00:00Biologics, Immunotherapy, and Future Directions in the Treatment of Advanced Cholangiocarcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-02-19 / Cancer Sci. 2019 Mar;110(3):849-857
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-02-19 / Cancer Sci. 2019 Mar;110(3):849-8572019-02-19 00:00:002019-07-01 08:21:29Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-02-12 / Br J Radiol 2019 Mar;92(1095):20180759
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-02-12 / Br J Radiol 2019 Mar;92(1095):201807592019-02-12 00:00:002019-02-12 00:00:00Mild hyperthermia as a localized radiosensitizer for deep-seated tumors: investigation in an orthotopic prostate cancer model in mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-02-06 / Front Oncol 2019;9:50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-02-06 / Front Oncol 2019;9:502019-02-06 00:00:002019-02-06 00:00:00On the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer Immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-02-01 / Immunotherapy 2019 Feb;11(2):75-79
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-02-01 / Immunotherapy 2019 Feb;11(2):75-792019-02-01 00:00:002019-02-01 00:00:00The evolving clinical landscape for dendritic cell vaccines and cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-02-01 / 2019 Feb;39(2):751-758
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-02-01 / 2019 Feb;39(2):751-7582019-02-01 00:00:002020-10-05 10:14:54Effect of High-dose Vitamin C Combined With Anti-cancer Treatment on Breast Cancer Cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-01-31 / 2019;10(1)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-01-31 / 2019;10(1)2019-01-31 00:00:002019-01-31 00:00:00Vitamin C in Cancer Therapeutics and Metastasis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-01-23 / Cancer Gene Ther. 2019 09;26(9-10):282-291
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-01-23 / Cancer Gene Ther. 2019 09;26(9-10):282-2912019-01-23 00:00:002019-01-23 00:00:00Dendritic cell vaccination plus low-dose doxorubicin for the treatment of spontaneous canine hemangiosarcoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-01-12 / Life Sci. 2019 Feb;219:136-143
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-01-12 / Life Sci. 2019 Feb;219:136-1432019-01-12 00:00:002019-01-12 00:00:00Induction of T cell-mediated immune response by dendritic cells pulsed with mRNA of sphere-forming cells isolated from patients with gastric cancer
